Detection of TSC alteration and molecular risk factor in cervical cancer.
Detection of TSC alteration and molecular risk factor in cervical cancer.
批准号:
11671617
负责人:
FUJITA Masami
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A TSC403 gene is the oncogene, which is recently identified as lung specific, and has homology with Lysosomal Membrane glycoproteins (lamps)-1, 2 which influences the metastasis of the cancer cell. The alteration of TSC403 gene was examined in the gynecological tumor. TSC403 gene mRNA overexpression was detected in 19 cases of 40 cases of uterine cervical cancer, 3 cases of 29 cases (48%) of uterine endometrial cancer and 3 cases of 33 cases (9%) of ovarian cancer. during 29 examples during 33 examples. The gene amplification or re-arrangement of the TSC403 gene was not detected by Southern-blot hybridization. The mRNA overexpression of the TSC403 gene was also analyzed in uterine cervical cancer cell lines, and detected in 2 cases of 5 cell lines (40%). The gene construct that a TSC403 gene mRNA was included into the expression vector was made, and the transformant was obtained from the uterine cervical cancer cell lines which does not express TSC403 gene mRNA.A functional analysis of … More the TSC403 gene became possible by this in vitro and in vivo.The E6 oncoproptein of HPV interact with the p53 protein, and it is thought that it play a major role in the carcinogenesis of cervical cancer by HPV.The p53 gene has a natural polymorphism, encoding either proline (p53Pro) or Arginine (p53Arg). It was reported that p53Arg was more susceptible to E6 mediated degradation than the p53Pro. We analyzed whether this polymorphism were concerned with the high risk factor of cervical cancer. The ratio of Arg and Pro was 0.54 : 0.30 : 0.16 in the 81 cases of cervical cancer and 0.42 : 0.47 : 0.11 in 329 cases of control. The frequency of p53Arg homozygotes was statistically high in the cervical cancer group. It is suggested that the pattern of p53codon72 polymorphism became the high risk factors of cancer. However, the frequency of p53Arg homozygotes is 40% in general population, p53Arg alone does not represent a specific risk marker for cervical cancer and an analysis including other risk factors should be was necessary. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Analysis of oncogenes involved in invasion or metastasis of endometrial cancer and detection of endometrial cancer stem cells
-
批准号:22591855
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2010
-
负责人:FUJITA Masami
-
依托单位:
国内基金
海外基金
登录
查看更多内容
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
-
批准号:82372743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈卓佳
-
依托单位:
脊髓电刺激活化Na(V)1.1阳性GABA神经元持续缓解癌痛
-
批准号:82371223
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:闻大翔
-
依托单位:
丁酸梭菌代谢物(如丁酸、苯乳酸)通过MYC-TYMS信号轴影响结直肠癌化疗敏感性的效应及其机制研究
-
批准号:82373139
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:李孟鸿
-
依托单位:
均相液相生物芯片检测系统的构建及其在癌症早期诊断上的应用
-
批准号:82372089
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:李万万
-
依托单位:
基于密度泛函理论金原子簇放射性药物设计、制备及其在肺癌诊疗中的应用研究
-
批准号:82371997
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张春富
-
依托单位:
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
-
批准号:82373145
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:历鹏
-
依托单位:
BRPF1 m6A修饰异常通过重塑BCAT1超级增强子介导Setd2缺陷型肾癌支链氨基酸代谢成瘾的机制研究
-
批准号:82372724
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:何竑超
-
依托单位:
基于影像代谢重塑可视化的延胡索酸水合酶缺陷型肾癌危险性分层模型的研究
-
批准号:82371912
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:吴广宇
-
依托单位:
EGFR通过激活β-catenin重塑肿瘤微环境代谢调控肿瘤免疫逃逸的分子机制研究
-
批准号:32100574
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:邵飞
-
依托单位:
脯氨酸羟化酶EglN1转位到线粒体介导乳腺癌细胞适应缺氧应激的机制研究
-
批准号:32100570
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:闫朝君
-
依托单位: